CN1061886C - Chinese medicinal composition for nascsinusitis - Google Patents

Chinese medicinal composition for nascsinusitis Download PDF

Info

Publication number
CN1061886C
CN1061886C CN97118897A CN97118897A CN1061886C CN 1061886 C CN1061886 C CN 1061886C CN 97118897 A CN97118897 A CN 97118897A CN 97118897 A CN97118897 A CN 97118897A CN 1061886 C CN1061886 C CN 1061886C
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
radix
nascsinusitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97118897A
Other languages
Chinese (zh)
Other versions
CN1217926A (en
Inventor
申付明
申志彬
申志芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97118897A priority Critical patent/CN1061886C/en
Publication of CN1217926A publication Critical patent/CN1217926A/en
Application granted granted Critical
Publication of CN1061886C publication Critical patent/CN1061886C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention discloses a traditional Chinese medicine composition for treating nascsinusitis, which is prepared from bulbus fritilariae, axonite root, ginkgo, chrysanthemum, oyster, rhizoma acori graminei, ginseng, notoginseng, genkwa flower and antler slice. By the clinical verification of 318 cases, the present invention has the characteristics of rapid disease symptom removal, consolidated curative effect, convenient administration and no toxic or side effect. The total effective rate is 100%, and the cure rate is more than 98 %. The traditional Chinese medicine composition is used for mainly treating nascsinusitis, and simultaneously, the traditional Chinese medicine composition has certain curative effect on rhinitis, metopantritis, nose clip hypertrophia, nasal polyp, stomatitis, ozostomia and cecidum.

Description

A kind of Chinese medicine composition for the treatment of sinusitis
The present invention relates to a kind of smelting and treat the Chinese medicine composition of the ball powder type of sinusitis.
At present, the method for treatment sinusitis has: 1) outer dripping method: main medicine has BITONG etc., is used for outside antiinflammatory, and its shortcoming is, is that antiinflammatory is alleviated, and the persistent period is short, can not effect a radical cure; 2) fumigation-washing therapy: on same has been mitigation in short-term; 3) puncture therapy: to the dense property of the intranasal liquid that the patient with severe symptoms forms, use the puncture method sucking-off, flushing repeatedly, defeated simultaneously antibiotics, this method cost is very high, but still does not reach the purpose of radical cure; 4) laser therapy: very easily destroy human body olfactory sensation and puncture the nose film, cause the human organ permanent damage, dangerous.
The object of the present invention is to provide and a kind ofly can thoroughly effect a radical cure the medicine of sinusitis.
The object of the present invention is achieved like this: it forms (weight ratio) by following Chinese medicine ingredients: Bulbus Fritillariae Cirrhosae 10-20 part, Radix Aconiti Lateralis Preparata 5-10 part, Semen Ginkgo 10-15 part, Flos Chrysanthemi 20-25 part, Concha Ostreae 10-15 part, Rhizoma Acori Graminei 20-25 part, Radix Ginseng 36-35 part, Radix Notoginseng 10-15 part, Flos Genkwa 5-7 part, piece of antler 10-15 part.
The present invention can also following manner realize: 10 parts of Bulbus Fritillariae Cirrhosae, 5 parts of Radix Aconiti Lateralis Preparatas, 10 parts of Semen Ginkgoes, 20 parts of Flos Chrysanthemis, 10 parts of Concha Ostreaes, 20 parts of Rhizoma Acori Graminei, 30 parts of Radix Ginsengs, 10 parts of Radix Notoginseng, 5 parts of Flos Genkwas, 10 parts of piece of antlers.
Dosage form is pill or powder.
Treatment mechanism of the present invention and effect: the present invention is a kind of therapy of drafting according to the integral viewpoint of the outer sick treatment by oral administration of medicines of Chinese medicine.The inventor through 10 years discover that sinusitis is not a kind of inflammation, but a kind of viral infection.Through repetition test, sum up and extract the above-mentioned case incomparably of joining for this reason.Through the clinical verification to 318 routine patients in nearly 5 years, wherein all kinds of sinusitis account for 69%, the nose clip hypertrophy accounts for 23%, nasal polyp accounts for 8%, and children account for 83%, and person in middle and old age account for 17%, most genus obstinate patients, through using traditional Chinese medicine composition for treating of the present invention, effective percentage 100%, cure rate is more than 98%.In 318 routine patients, except that 2 because of adopting laser therapy to cause nasal perforation fails to cure, all the other are all fully recovered.To eyebrow rib and the preceding brow pang that acute sinusitis causes, as long as dosage is taken, can in one hour, remove misery, curative effect is also very remarkable.
Chinese medicine composition of the present invention the experiment proved that, has that to remove symptom fast, the cure rate height, and efficacy consolidation, taking convenience, remarkable advantage such as have no side effect.
Elaborate below in conjunction with embodiment:
Chinese medicine composition title of the present invention: nasal sinusitis spirit.
Cure mainly: sinusitis.
Cure mainly: sinusitis.
Double controlling: rhinitis, frontal sinusitis, nose clip hypertrophy, nasal polyp, stomatitis, halitosis, folder wart.
Composition and proportioning: 10 parts of Bulbus Fritillariae Cirrhosae, 5 parts of Radix Aconiti Lateralis Preparatas, 10 parts of Semen Ginkgoes, 20 parts of Flos Chrysanthemis, 10 parts of Concha Ostreaes, 20 parts of stone Chang fore-tellings, 30 parts of Radix Ginsengs, 10 parts of Radix Notoginseng, 5 parts of Flos Genkwas, 10 parts of piece of antlers more than are part by weight.
Dosage form: pill or powder.
Preparation method: mix after each Chinese medicinal components drying, pulverize, promptly can be made into powder; Add water by powdery powder, promptly can be made into the pill of Semen phaseoli radiati size.
Usage and dosage: for oral administration, day clothes 3-5 time, each 3-5 gram.

Claims (3)

1, a kind of Chinese medicine composition for the treatment of sinusitis, it is characterized in that, form (weight ratio): Bulbus Fritillariae Cirrhosae 10-20 part, Radix Aconiti Lateralis Preparata 5-10 part, Semen Ginkgo 10-15 part, Flos Chrysanthemi 20-25 part, Concha Ostreae 10-15 part, Rhizoma Acori Graminei 20-25 part, Radix Ginseng 30-35 part, Radix Notoginseng 10-15 part, Flos Genkwa 5-7 part, piece of antler 10-15 part by following Chinese medicine ingredients.
2, the Chinese medicine composition of treatment sinusitis according to claim 1, it is characterized in that the part by weight of each Chinese medicine ingredients is: 10 parts of Bulbus Fritillariae Cirrhosae, 5 parts of Radix Aconiti Lateralis Preparatas, 10 parts of Semen Ginkgoes, 20 parts of Flos Chrysanthemis, 10 parts of Concha Ostreaes, 20 parts of Rhizoma Acori Graminei, 30 parts of Radix Ginsengs, 10 parts of Radix Notoginseng, 5 parts of Flos Genkwas, 10 parts of piece of antlers.
3, according to the Chinese medicine composition of claim 1,2 described treatment sinusitis, it is characterized in that: dosage form is pill or powder.
CN97118897A 1997-11-15 1997-11-15 Chinese medicinal composition for nascsinusitis Expired - Fee Related CN1061886C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97118897A CN1061886C (en) 1997-11-15 1997-11-15 Chinese medicinal composition for nascsinusitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97118897A CN1061886C (en) 1997-11-15 1997-11-15 Chinese medicinal composition for nascsinusitis

Publications (2)

Publication Number Publication Date
CN1217926A CN1217926A (en) 1999-06-02
CN1061886C true CN1061886C (en) 2001-02-14

Family

ID=5175050

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97118897A Expired - Fee Related CN1061886C (en) 1997-11-15 1997-11-15 Chinese medicinal composition for nascsinusitis

Country Status (1)

Country Link
CN (1) CN1061886C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102283896B (en) * 2011-08-19 2013-04-03 靳晋生 Drug for curing chronic allergic rhinitis
CN103028037A (en) * 2012-12-18 2013-04-10 张玉辉 Traditional Chinese medicine prescription for treating allergic rhinitis
CN104857605A (en) * 2015-06-26 2015-08-26 许勤峰 Special drug deliverer for treating middle nasal meatus polyps and traditional Chinese medicine thereof for external application
CN105031209A (en) * 2015-07-01 2015-11-11 兰永海 Orally-taken traditional Chinese medicine pill capable of eliminating frontal sinusitis and relieving pain and preparation method thereof
CN106620053A (en) * 2016-11-09 2017-05-10 鄢庆敏 Capsule for treating goiter disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
山东中医飞机场1991,10(2) 1991.1.1 徐献军 仙方活命饮加味治疗鼻渊68例 *
山东中医飞机场1991,10(2) 1991.1.1 徐献军 仙方活命饮加味治疗鼻渊68例;新中医1990,22(11) 1990.1.1 廖秋源 补中益气汤的临床运用 *
新中医1990,22(11) 1990.1.1 廖秋源 补中益气汤的临床运用 *

Also Published As

Publication number Publication date
CN1217926A (en) 1999-06-02

Similar Documents

Publication Publication Date Title
CN101066421A (en) Plaster for treating cholecystitis, cholangitis and bile gastritis
CN1480189A (en) Medication for treating rhinitis
CN104352587A (en) Ointment for treating rhinitis
CN1061886C (en) Chinese medicinal composition for nascsinusitis
CN101703701B (en) Medicament for treating facioplegia
CN1686243A (en) Chinese medicinal formula for treating chronic bronchitis
CN102552734B (en) Gargle for treating dental ulcer
CN103316202B (en) Preparation method of oral-dissolving sustained-release traditional Chinese medicine used for treating nasopharyngitis
CN102847030A (en) Freckle-removal facial mask
CN102600343A (en) Chinese medicinal preparation for treating oral diseases and/or toothache
CN1056517C (en) Anal fistula eliminating medicine
CN101732424B (en) Chinese medicinal powder for treating pharyngitis
CN1133446C (en) Gufukang liniment for treating bone disease
CN102755608A (en) External application medicine for treating bronchitis
CN107158078A (en) Special efficacy Chinese herb medicine powder for rhinitis and rhinitis ointment
CN102552686A (en) Traditional Chinese medicinal aerosol for treating chronic pharyngitis in clinical care
Koshta et al. Herbal Formulations Used for Treatment/Management of Cancer
CN1969960A (en) Pharmaceutical composition for treating acne and application method thereof
CN100479845C (en) Medicinal composition for treating chronic rhinitis and preparation method thereof
CN103463236B (en) Medicinal composition and preparation method thereof
CN1393243A (en) Chinese medicine for treating tuberculosis
CN105943584A (en) Medicine for treating dental ulcer
CN1389244A (en) Rhinitis-treating clove ointment
CN105125802A (en) Orifice clearing rhinitis paste
CN104958351A (en) Pharmaceutical composition for treating pneumoconiosis

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1019733

Country of ref document: HK